"Supportive care" may hold less stigma than "palliative care"
the ONA take:
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care and were conducive to referral with the service name supportive care instead of palliative care, a new study published online ahead of print in the journal The Oncologist has shown.
Because palliative care referrals are often delayed for patients with hematologic malignancies, researchers sought to examine the differences in attitudes and beliefs toward palliative care referral between hematologic and solid tumor specialists and how their perception was altered with the service name supportive care instead of palliative care.
For the study, researchers surveyed 120 hematologic and 120 solid tumor oncology specialists at University of Texas MD Anderson Cancer Center in Houston, Texas.
Results showed that hematologic specialists were less likely than solid tumor specialists to report that they would refer symptomatic patients with newly diagnosed cancer to palliative care.
Researchers also found that a significantly greater proportion of oncology specialists reported that they would refer a patient with newly diagnosed cancer to supportive care than palliative care, even though they both provide the same service.
“These findings suggest that rebranding might help to overcome the stigma associated with palliative care and improve patient access to palliative care services,” the authors conclude.
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|